美股市場個股詳情

CLRB Cellectar BioSciences

添加自選

3.1800
+0.1200+3.92%

收盤價 05/14 16:00 (美東)

3.2300
+0.0500+1.57%

盤前 05:39 (美東)

1.14億總市值-1029市盈率TTM

Cellectar BioSciences股票討論區

登錄發表評論

Trytosaveabit

03/04 19:45

Update

$Cellectar BioSciences(CLRB.US)$ Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
4 MINUTES AGO, 6:40 AM EST
VIA GLOBENEWSWIRE

JESSE JAMES8832

01/30 19:45

Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study

$Cellectar BioSciences(CLRB.US)$

Trytosaveabit

01/25 19:47

Update

$Cellectar BioSciences(CLRB.US)$ Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million

Trytosaveabit

01/22 19:43

Update

$Cellectar BioSciences(CLRB.US)$ Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom's Macroglobulinemia Patient
2 MINUTES AGO, 6:40 AM EST
VIA GLOBENEWSWIRE

Meltyy

01/12 23:27

Biotech Stock News 01/12 @ Open 🛎️📰
$戴納基(DYN.US)$ 4% Closing of public offering
$傑龍(GERN.US)$ 4% Participate @ B. Riley Sec. Conf. '24
$ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS(ZEAL.US)$ 2% Capital increase
$標記臨床研究(XOMA.US)$ 1% Arimoclomol NDA filing accepted
$Cellectar BioSciences(CLRB.US)$ 1% Topline results @ conf. call
$CytomX(CTMX.US)$ 0% Present @ B. Riley Sec. Conf. '24

Trytosaveabit

01/11 19:47

Update

$Cellectar BioSciences(CLRB.US)$ Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting